Biomarkers of Type 2 Airway Inflammation as Predictors of Loss of Asthma Control During Step-Down Therapy for Well-Controlled Disease: The Long-Acting Beta-Agonist Step-Down Study (LASST)

BACKGROUND: Biomarkers that can predict loss of asthma control among patients being considered for step-down therapy in well-controlled disease are lacking. OBJECTIVE: To evaluate whether baseline biomarkers of type 2 airway inflammation and/or serial measurement of fractional exhaled nitric oxide (...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Allergy Clin Immunol Pract
Asıl Yazarlar: Bose, Sonali, Bime, Christian, Henderson, Robert J., Blake, Kathryn V., Castro, Mario, DiMango, Emily, Hanania, Nicola A., Holbrook, Janet T., Irvin, Charles G., Kraft, Monica, Peters, Stephen P., Reibman, Joan, Sugar, Elizabeth A., Sumino, Kaharu, Wise, Robert A., Rogers, Linda
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8026280/
https://ncbi.nlm.nih.gov/pubmed/32693214
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2020.06.067
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller